Skip Navigation
Skip to contents



5 results

Huge Bilateral Breast Hamartoma Accompanied with Pseudoangiomatous Stromal Hyperplasia

Baik H, Kim JW, Park YM, Jung SJ, Lee A, Yoon HK, Kim TH

  • J Breast Dis.
  • 2016 Jun;4(1):28-32.
  • doi: 10.14449/jbd.2016.4.1.28
A 34-year-old woman presented with sudden breast enlargement that had occurred within 6 months. She also had an accessory breast mass on the left axilla. Clinical impression was phyllodes tumor....
The Results of Occult Breast Carcinoma Treated with Axillary Node Dissection Only: Five Cases Reports

Kim Y, Kim H, Cho J, Kwon S, Yeo S, Kang SH

  • J Breast Dis.
  • 2016 Jun;4(1):24-27.
  • doi: 10.14449/jbd.2016.4.1.24
Herein, we report five cases of occult breast cancer treated with axillary node dissection only, without breast surgery or whole breast radio-therapy. The patients complained of a large, hard mass...
Predictors for the Transition from Ductal Carcinoma In Situ to Invasive Breast Cancer in Korean Patients

Kim EY, Hyun KH, Park YL, Park CH, Do SI

  • J Breast Dis.
  • 2016 Jun;4(1):16-23.
  • doi: 10.14449/jbd.2016.4.1.16
PURPOSE: To identify predictive factors of upstaging from diagnosed ductal carcinoma in situ (DCIS) to invasive cancer after surgical excision. METHODS: One hundred seventy-four patients diagnosed with DCIS based on biopsies...
Clinicopathologic Features of Pleomorphic Invasive Lobular Carcinoma: Comparison with Classic Invasive Lobular Carcinoma

Yeom C, Kim H, Kwon S, Kang SH

  • J Breast Dis.
  • 2016 Jun;4(1):10-15.
  • doi: 10.14449/jbd.2016.4.1.10
PURPOSE: The purpose of this study was to identify the clinical and pathological factors that differentiate pleomorphic invasive lobular carcinoma (PILC) from classic invasive lobular carcinoma (CILC). METHODS: We retrospectively reviewed...
Clinical Implications of Genetic Testing for Hereditary Breast and Ovarian Cancer Syndrome in the Era of Genomic Medicine: Clinician's Perspectives

Park HS, Park JS, Nam EJ, Lee ST, Han JW, Kim TI

  • J Breast Dis.
  • 2016 Jun;4(1):1-9.
  • doi: 10.14449/jbd.2016.4.1.1
Hereditary breast and ovarian cancer syndrome accounts for approximately 5% to 10% of breast or ovarian cancers, with which the high-penetrant BRCA1/2 genes have been associated. With the recent development...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: